Construction of a Prefabricated Modular Building for a Thermal Disinfection and Decontamination Station for Pathogenicity Groups III–IV Effluents

INEX Group has officially commenced a project to develop and implement advanced engineering solutions for wastewater decontamination at Sputnik Technopolis in Moscow.

Part of the R-Pharm pharmaceutical group, Sputnik Technopolis stands as one of the largest and most sophisticated biotechnological complexes in Russia and Eastern Europe. The facility plays a critical role in national healthcare as a primary production site for the flagship Russian COVID-19 vaccine, Sputnik V.

[Image: Overview of a high-tech biopharmaceutical production complex]

Project Milestones & Technical Audit: The project began with a comprehensive site survey and a technical working meeting to evaluate the facility's existing decontamination infrastructure.

• Technical Audit: INEX specialists conducted a deep-dive assessment of the current wastewater treatment technologies.

• Expert Reporting: A detailed audit report has been delivered to the Client, outlining optimization paths and safety enhancements.

• System Integration: INEX is currently developing specialized project solutions for the supply and installation of its proprietary UTOS-1-3000 wastewater decontamination unit.

[Image: Flow diagram of a high-capacity thermal sterilization unit for biopharmaceutical effluents]

The UTOS-1-3000 Advantage: The UTOS-1-3000 is an in-house developed thermal treatment system designed for large-scale biotechnological sites. It ensures:

• Total Pathogen Inactivation: Guaranteed neutralization of biological agents used in vaccine production.

• High Throughput: Engineered to handle the significant discharge volumes of a major manufacturing hub.

• Automated Safety: Integration of continuous monitoring systems to prevent the discharge of untreated waste into municipal networks.